Related Experiment Video
Updated: May 27, 2025

14:48
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
5.0K
Reprogramming Lung Redox Homeostasis by NIR Driven Ultra-Small Pd Loaded Covalent Organic Framework Inhibits NF-κB
Doudou Lei1, Lin Liao2, Tao Qin3
1Intensive Care Unit, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530 007, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|February 18, 2025
Summary
This study introduces a novel TP@Pd nanozyme therapy combined with near-infrared irradiation to treat acute lung injury (ALI). The treatment effectively reduces inflammation and reactive oxygen species (ROS), promoting lung tissue repair.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Immunotherapy
Background:
- Acute lung injury (ALI) is characterized by inflammation and oxidative stress.
- Reprogramming lung redox homeostasis is a promising therapeutic strategy for ALI.
- Reactive oxygen species (ROS) play a critical role in ALI pathogenesis.
Purpose of the Study:
- To develop a novel nanozyme-based therapy for ALI.
- To investigate the efficacy of TP@Pd combined with near-infrared (NIR) irradiation for ALI treatment.
- To elucidate the underlying mechanisms of TP@Pd+NIR in ameliorating lung injury.
Main Methods:
- Synthesis of ultra-small Palladium (Pd) loaded covalent organic framework (TP@Pd).
- Evaluation of TP@Pd nanozyme activity under NIR irradiation.
- Assessment of therapeutic effects in an ALI rat model, including biochemical assays, histological analysis, and immune cell profiling.
Main Results:
- TP@Pd nanoparticles exhibited nanozyme functionalities and broad-spectrum ROS scavenging.
- The TP@Pd+NIR strategy significantly reduced ROS and inflammatory cytokines (IL-6, TNF-α, IL-1β).
- Treatment promoted M2 macrophage polarization, enhanced immunoregulation, and accelerated tissue repair by upregulating SOD2, HSP70, and CD31.
Conclusions:
- The TP@Pd+NIR strategy offers a synergistic approach for ALI amelioration.
- This novel therapy effectively alleviates lung inflammation and promotes tissue repair.
- This approach holds potential for treating ROS-related diseases beyond ALI.

